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Candida albicans, a constituent of normal microbial flora of human mucosal surfaces,
is a major cause of candidemia in immunocompromised individuals and hospitalized
patients with other debilitating diseases. Molecular fingerprinting studies have suggested
nosocomial transmission of C. albicans based on the presence of clusters or endemic
genotypes in some hospitals. However, intrahospital strain transmission or a common
source of infection has not been firmly established. We performed multilocus sequence
typing (MLST) on 102 C. albicans bloodstream isolates (representing 92% of all
culture-confirmed candidemia patients over a 31-month period at seven major hospitals)
to identify patient-to-patient transmission or infection from a common source in Kuwait,
a small country in the Middle East where consanguineous marriages are common.
Repeat bloodstream isolates from six patients and nine surveillance cultures from
other anatomic sites from six patients were also analyzed. Fifty-five isolates belonged
to unique genotypes. Forty-seven isolates from 47 patients formed 16 clusters, with
each cluster containing 2–9 isolates. Multiple isolates from the same patient from
bloodstream or other anatomical sites yielded identical genotypes. We identified four
cases of potential patient-to-patient transmission or infection from a common source
based on association analysis between patients’ clinical/epidemiological data and
the corresponding MLST genotypes of eight C. albicans isolates. However, further
fingerprinting by whole genome-based amplified fragment length polymorphism (AFLP)
analysis yielded 8 different genotypes, ruling out intrahospital transmission of infection.
The findings suggest that related strains of C. albicans exist in the community and
fingerprinting by MLST alone may complicate hospital infection control measures during
outbreak investigations.
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INTRODUCTION
Candida and other yeast species, like many bacteria, are part of normal microbial flora of skin
and mucosal surfaces of the gastrointestinal and genitourinary tracts in humans and give rise
to opportunistic infections when host defenses are compromised (Kumamoto, 2011; McManus
and Coleman, 2014). The isolation of Candida species is higher from individuals receiving
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broad-spectrum antibiotics or corticosteroid treatment or
those with other underlying conditions that compromise host
immunity such as diabetes, extremes of age (neonates and
elderly), pregnancy and human immunodeficiency virus (HIV)
infection (Vincent et al., 2009; Liu et al., 2015; Sun et al.,
2016). Typically, these conditions also predispose the colonized
individuals to invasive infections by Candida species (Vincent
et al., 2009; Kett et al., 2011). Although, many Candida species
are of clinical importance in humans, Candida albicans is the
most prevalent and most pathogenic species causing the majority
of cases of oral and systemic candidiasis as well as candidemia
in hospitalized patients (Leroy et al., 2009; Neofytos et al., 2010;
Pfaller et al., 2011; Zomorodian et al., 2011). Although, C.
dubliniensis is another yeast capable of forming true hyphae, it
is significantly less pathogenic, causing invasive infections much
less frequently than C. albicans (Stokes et al., 2007; Moran et al.,
2012).
The epidemiology and origin of nosocomial C. albicans
among candidemia patients can be studied by molecular
characterization and fingerprinting of single isolates from
individual patients by highly effective molecular typing
systems capable of discriminating closely related but non-
identical isolates (McManus and Coleman, 2014). Multilocus
microsatellite typing (MLMT) based on variations in stretches
of tandemly repeated sequences and multilocus sequence typing
(MLST) based on single nucleotide polymorphisms in DNA
fragments of housekeeping genes with discriminatory powers
of 0.987 and 0.999, respectively, are comparable to the more
tedious Ca3-based fingerprinting (discriminatory power of 0.93)
and are considered sufficient to discriminate even closely related
strains (Bougnoux et al., 2003; Tavanti et al., 2003; Sampaio
et al., 2005; Odds and Jacobsen, 2008). Of these, MLST is a
standardized scheme based on 7 conserved housekeeping genes,
is slightly more discriminatory, and has a publicly accessible
and curated online C. albicans MLST database for worldwide
comparisons (http://pubmlst.org/calbicans/). As of December
23, 2016, 4318 C. albicans isolates have been classified into 3268
diploid sequence types (DSTs) belonging to 18 different clades
(McManus and Coleman, 2014; http://pubmlst.org/calbicans/).
Although, MLMT and MLST have high discriminatory power,
they are considered inferior to genome wide techniques
particularly whole genome sequencing or whole genome
multilocus sequence typing (Fitzpatrick et al., 2016; Kwong et al.,
2016; Roisin et al., 2016). Previous studies based on MLMT
and MLST have reported the presence of endemic genotypes
of C. albicans within the same hospital units that were likely
involved in intrahospital transmission of infection, however,
patient-to-patient transmission of infection was not conclusively
proven (Asmundsdóttir et al., 2008; Maganti et al., 2011; Shin
et al., 2011; Escribano et al., 2013; Marcos-Zambrano et al., 2015;
Wu et al., 2015). Patient-to-patient intrahospital transmission of
infection was also presumed for nosocomial bacterial pathogens
like Staphylococcus aureus based on fingerprinting by MLST
(McBryde et al., 2004; SenGupta et al., 2014; Ugolotti et al., 2016).
However, whole genome sequence-based high-resolution genetic
analyses did not support intrahospital transmission of S. aureus
between patients with invasive infections. These studies also
showed that highly related pools of bacterial strains exist which
could not be differentiated by low-resolution typing methods
such as MLST (Nübel et al., 2013; Long et al., 2014; Price et al.,
2014). It is, therefore, probable that the presumed intrahospital
transmission of C. albicans described in some studies may have
been inferred from low-resolution typing methods such as
MLMT or MLST which may not have been supported by high-
resolution genetic analyses based on whole genome sequencing
studies. Since whole genome sequencing is not yet routine for
fungi, an alternative approach may involve initial fingerprinting
byMLST followed by other whole genome-based high-resolution
fingerprinting methods on epidemiologically-related isolates for
detecting possible patient-to-patient transmission of infection or
infection from a common source.
This study performed molecular fingerprinting of C. albicans
isolated from 102 candidemia patients (representing 92% of all
culture-confirmed candidemia patients at seven major hospitals)
in Kuwait by MLST. Potential cases of nosocomial transmission
of infection based on epidemiological data and identical MLST
genotypes were further studied by fingerprinting by whole
genome-based amplified fragment length polymorphism (AFLP)
analyses for confirmation of intrahospital transmission of
infection.
MATERIALS AND METHODS
Reference Strains and Clinical Isolates
Reference strains of C. albicans (ATCC 90028), Candida
parapsilosis (ATCC 22019), C. parapsilosis (CBS1954), and C.
parapsilosis (CBS6318) were used in this study. A total of
171 candidemia episodes were recorded among 111 patients
at the seven major hospitals in Kuwait during January 2011
to July 2013. Of these, first blood culture C. albicans isolates
from 102 patients were available for fingerprinting studies.
Additionally, repeat (duplicate) bloodstream C. albicans isolates
from six (patient no. 2, 5, 26, 60, 73, and 92) patients and nine
surveillance cultures from six (patient no. 26, 33, 48, 53, 73,
and 83) patients were also included. Blood and other clinical
specimens were collected at various hospitals across Kuwait
after obtaining verbal consent from patients as part of routine
patient care for the isolation of fungal pathogens. The isolates
were sub-cultured on Sabouraud dextrose agar medium for
identification and antifungal susceptibility testing and data were
analyzed anonymously. The consent procedure and the study
were approved by the Joint Committee for the Protection of
Human Subjects in Research, Health Sciences Center, Kuwait
University and Ministry of Health, Kuwait.
The age of the patients ranged from newly born to 106 years.
Ninety patients were Kuwaiti nationals while only 12 patients
were expatriates originating from four different countries
(Supplementary Table 1). Majority (70, 69%) of the patients were
adults while 24 of the 32 pediatric patients were neonates. The
highest number of C. albicans were analyzed from Mubarak Al-
Kabeer Hospital (n = 27) followed by Maternity Hospital (n
= 21), Ibn-Sina Hospital (n = 17), Farwaniya Hospital (n =
14), Al-Sabah Hospital (n = 8), Jahra Hospital (n = 8) and
Amiri Hospital (n= 7). Only three (Maternity Hospital, Ibn-Sina
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Hospital and Al-Sabah Hospital) of these hospitals are within
1 km of each other while the remaining hospitals are situated
>10 km apart. All clinical isolates were initially identified as
C. albicans by commercial CHROMagar Candida and Vitek2
yeast identification system (bioMérieux, Marcy-lEtoile, France).
Genomic DNA from each isolate was prepared as described
previously (Ahmad et al., 2004). The identity of each isolate was
confirmed by duplex PCR targeting the ITS region of rDNA
and/or by DNA sequencing of rDNA, as described previously
(Ahmad et al., 2012).
Antifungal Drug Susceptibility Testing
The susceptibility of C. albicans isolates against antifungal drugs,
amphotericin B (AMB), fluconazole (FLU), voriconazole (VOR),
and caspofungin (CFG) was determined by E-test (AB Biodisk,
Solna, Sweden) on RPMI agar (supplemented with 2% glucose
and buffered with MOPS, 0.165 M, pH 7.0) plates according
to manufacturer’s recommendations and as described previously
(Asadzadeh et al., 2008). Briefly, each isolate was resuspended
in sterile normal saline and the turbidity was adjusted to 0.5
McFarland unit. The plates were inoculated with the uniform
suspension by using a cotton swab, Etest strips were applied,
the plates were incubated at 35◦C and read after 24 h. The
minimum inhibitory concentration (MIC) values (µg/ml) were
recorded for each drug and MIC50 and MIC90 values were also
calculated. The revised interpretive susceptibility breakpoints
as recommended by Clinical Laboratory Standards Institute
(CLSI) were used for FLU (≤2 µg/ml, susceptible; 4 µg/ml,
susceptible dose-dependent and ≥8 µg/ml, resistant), VOR
(≤0.125µg/ml, susceptible; 0.25–0.5µg/ml, intermediate and≥1
µg/ml, resistant) and CFG (≤0.25 µg/ml, susceptible; 0.5 µg/ml,
intermediate and ≥1 µg/ml, resistant) (Clinical and Laboratory
Standards Institute, 2012). Due to lack of defined breakpoints
for AMB, an isolate showing MIC ≤1.0 µg/ml was considered
as susceptible. Quality control was ensured by testing C. albicans
ATCC 90028 and C. parapsilosis ATCC 22019, as recommended
by CLSI.
Molecular Fingerprinting of C. albicans
Isolates by MLST
A total of seven (AAT1, ACC1, ADP1, MPI1, SYA1, VPS13,
and ZWF1b) housekeeping gene fragments recommended as
an international standard for C. albicans MLST were used, as
described previously (Bougnoux et al., 2003). The oligonucleotide
primers (sequences of primers are publicly available at the
C. albicans MLST database homepage (http://pubmlst.org/
calbicans/) were synthesized and used for PCR amplification
of the seven genes. Amplification of each gene fragment was
performed by PCR using genomic DNA from each isolate, as
described previously (Bougnoux et al., 2003). The amplicons
were purified by using PCR product purification kit according
to the instructions supplied by the kit manufacturer (Qiagen).
Both strands were sequenced by using BigDye terminator
DNA sequencing kit (ABI Prism BigDye terminator v3.1,
Applied Biosystems) using the same primers as used for PCR
amplification for each DNA fragment. The sequencing products
were processed and loaded on the capillaries of the DNA
sequencer (ABI Prism 3130xl Genetic Analyser) as directed by
the manufacturer of the automated DNA sequencer (Applied
Biosystems) and as described previously (Asadzadeh et al., 2015).
Each allele profile was checked in both forward and reverse
sequence by using Clustal omega (http://www.ebi.ac.uk/Tools/
msa/clustalo/) and each sequence chromatogram was reviewed
for heterozygous (two equally strong and overlayed fluorescence
peaks) nucleotide positions. The allele number and diploid
sequence type (DST) for each isolate was assigned according to C.
albicans database. The allelic profiles that could not be assigned to
an existing DST were consequently added to the MLST database
(http://pubmlst.org/calbicans/).
Based on the allele number for the seven gene fragments
for each isolate, a dendrogram was constructed by using
BioNumerics v7.5 software (Applied Maths, Sint-Martens-
Latem, Belgium) and standard unweighted pair group
method with arithmetic mean (UPGMA) settings. The genetic
relationship between the genotypes was studied by constructing a
minimum spanning tree. The isolates were considered belonging
to the same DST when they contained the same alleles for
all seven loci. A cluster was defined as the same DST causing
bloodstream infection in two or more candidemia patients.
AFLP Analysis of Similar and
Epidemiologically Related C. albicans
Isolates
Cluster C. albicans isolates with identical MLST-based genotype
(DST) and epidemiological linkage with respect to their isolation
from the same hospital within a period of 60 days were
further analyzed by AFLP analysis. A total of eight C. albicans
isolates in four clusters (2 isolates in each), all isolated from
candidemia patients in 2011, were used. The AFLP analysis
was carried out as described in detail previously (Illnait-
Zaragozí et al., 2012). Briefly, 50 ng of genomic DNA was
mixed with restriction-ligation mixture containing restriction
enzymes EcoR1 and MseI (New England Biolabs, Beverly, MA,
USA) and their corresponding complementary adaptors. Prior
to further use, the restriction-ligation reaction was diluted by
adding 80 µl of 10 mM Tris-HCl (pH 8.3) buffer and one
microliter of the diluted product was used for amplification
in a total volume of 25 µl by using the selective primers
EcoR1 (5′-FLU-GACTGCGTACCAATTCAC-3′) and MseI (5′-
GATGAGTCCTGACTAAC-3′) (Illnait-Zaragozí et al., 2012).
One microliter of a 10-fold dilution of amplified products was
added to a mixture of 8.9 µl water and 0.1 µl LIZ600 internal size
marker (Applied Biosystems) and the contents were loaded for
fragment analysis on an ABI 3500xL Genetic Analyzer according
to the instructions of the manufacturer (Applied Biosystems). C.
albicans reference strain (ATCC 90028) was used as a control and
three reference strains (ATCC22019, CBS1954, and CBS6318) of
C. parapsilosiswere used as an out group. Raw data were analyzed
by using BioNumerics v6.6 software and a dendrogram was
generated using standard Pearson and unweighted pair group
method with arithmetic mean (UPGMA) settings. A cut-off value
of ≤95% similarity index among AFLP patterns was used for
defining a distinct genotype (Asadzadeh et al., 2015).
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Statistical Analysis
Categorical variables were expressed as absolute number.
Statistical analysis was performed using chi-square test or Fisher’s
exact test as appropriate and probability levels <0.05 by the two-
tailed test were considered as statistically significant. Statistical
analyses were performed using WinPepi software ver. 3.8 (PEPI
for Windows, Microsoft Inc., Redmond, WA, USA).
RESULTS
Distribution of Episodes of Candidemia at
Seven Major Hospitals in Kuwait
Kuwait is a small Arabian Gulf country with nearly 1.3
million Kuwaiti and a larger (∼3 million) ethnically diverse but
mostly younger (20–50 year) and medically screened expatriate
population. All residents receive nearly free medical treatment
in government-run hospitals. Nearly 40–50 culture-confirmed
cases of candidemia due to C. albicans occur every year at
seven of the nine major/tertiary-care hospitals of the Ministry
of Health, Government of Kuwait, where candidemia patients
are mainly diagnosed and treated. These seven hospitals serve
a large (∼85%) proportion of Kuwait’s multinational population
and the location of these hospitals within Kuwait is shown in
Supplementary Figure 1. During the 31-month (January 2011
to July 2013) study period, 111 culture-confirmed candidemia
patients due to C. albicans were treated at these seven hospitals
(Table 1). The highest number of candidemia cases were
diagnosed and treated at Mubarak Al-Kabeer Hospital (n = 29)
followed by Maternity Hospital (n = 22), Ibn-Sina Hospital (n
= 19) and Farwaniya Hospital (n = 14) while the remaining
27 patients were treated at the remaining three hospitals. A
total of 102 C. albicans bloodstream isolates recovered from 102
candidemia patients (representing 92% of all individual patient
isolates from seven hospitals) were available for fingerprinting
studies (Table 1). Most (90, 88%) of the patients were Kuwaiti
nationals while only 12 patients were expatriates originating
from four different countries (Supplementary Table 1). Majority
(70, 69%) of the patients were adults while 24 of the 32
pediatric patients were neonates. All patients from Maternity
Hospital (n = 21) were admitted to an intensive care unit
(ICU) and mostly (17 of 21) included pre-term low birth-
weight neonates on total parenteral nutrition. Overall, 47 of 102
bloodstream isolates were obtained from patients in an intensive
care unit (Supplementary Table 1). For some patients, duplicate
or multiple isolates were grown from repeated blood samples,
typically within 1 week of isolation of the first blood culture.
Surveillance cultures from different anatomic sites were also
obtained from hospitalized patients. Thirty-two (31%) patients
had multiple bloodstream isolates, including 12 patients with two
isolates, 16 patients with three isolates, three patients with four
isolates and one patient with five isolates. Duplicate bloodstream
isolates from six patients and 9 surveillance cultures from
other anatomic sites from six patients were also included for
MLST analyses to determine whether C. albicans isolates causing
candidemia or multiple episodes of candidemia were genetically
similar or distinct strains and their relationship with colonizing
strains. All 117 isolates were identified as C. albicans by the Vitek
2 yeast identification system, CHROMagar Candida and a duplex
PCR assay or by PCR sequencing of rDNA (Ahmad et al., 2012).
Antifungal Susceptibility Testing
All 102 bloodstream C. albicans isolates were tested for in
vitro antifungal drug susceptibility against four antifungal drugs,
viz. fluconazole (FLU), voriconazole (VOR), amphotericin B
(AMB) and caspofungin (CSF) by Etest. The distribution of
minimum inhibitory concentration (MIC) values of 102 C.
albicans isolates are summarized inTable 2. A total of 101 isolates
were susceptible to all four antifungal agents according to the
CLSI breakpoints for C. albicans while one isolate (Kw1104) was
resistant to both fluconazole and voriconazole but susceptible to
amphotericin B and caspofungin. The duplicate isolates as well
as the nine surveillance cultures were susceptible to all antifungal
drugs tested.
Fingerprinting of C. albicans Isolates by
MLST
Fingerprinting of bloodstream C. albicans isolates was carried
out to ascertain patient-to-patient or nosocomial transmission of
TABLE 1 | Number of culture confirmed candidemia episodes recorded at seven major hospitals in Kuwait and number of C. albicans isolates analyzed
by MLST.
Hospital No. of candidemia No. of No. of individual patient No. of duplicate and surveillance
episodes* patients isolates available for MLST cultures used for MLST
Mubarak Al-Kabeer 43 29 27 1
Maternity 50 22 21 9
Ibn-Sina 25 19 17 2
Farwaniya 16 14 14 −
Al-Sabah 15 9 8 2
Jahra 10 9 8 −
Amiri 12 9 7 1
Total 171 111 102 15
*Repeat isolates were cultured from some candidemia patients.
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TABLE 2 | In vitro susceptibility of 102 bloodstream C. albicans isolates
against four antifungal drugs.
Antifungal agent Minimum inhibitory concentration (MIC, µg/ml)
Range MIC50 MIC90
Amphotericin B 0.002–0.75 0.047 0.125
Fluconazole 0.023–>256 0.38 0.75
Voriconazole 0.002–>32 0.016 0.25
Caspofungin 0.002–0.38 0.125 0.25
MIC50 and MIC90, MIC required to inhibit 50% and 90% of the isolates, respectively.
One isolate (Kw1104) belonging to DST1056 was resistant to both fluconazole and
voriconazole.
infection in hospitalized candidemia patients. For this purpose,
C. albicans isolates yielding unique DST were considered as
genotypically distinct strains while isolates yielding the sameDST
were considered as candidates for possible patient-to-patient
or nosocomial transmission of infection. However, patient-to-
patient or nosocomial transmission of infection was considered
as likely only if the two isolates yielding identical DST were
related with respect to both, time and space, i.e., they were
collected from two or more patients from the same hospital and
within a short period of time. An arbitrary window period of≤60
days was used to define epidemiologically related isolates with
identical DST collected from two or more patients from the same
hospital. The location of the hospitalized patients in different
units was not used to exclude epidemiological linkage since
patients are oftenmoved within the hospital and this information
is not always readily available.
Fingerprinting of 102 C. albicans bloodstream isolates from
102 patients identified 71 different DSTs including six novel
alleles (three new AAT1α alleles, two MPIb alleles and one
VPS13 allele) identified for the first time in this study. Thirty-
seven of 71 DSTs have been identified previously and described
in the MLST database (http://pubmlst.org/calbicans/) while 34
DSTs have been identified for the first time (Supplementary
Table 1). Thirty-one of the 34 new DSTs were represented by
bloodstream isolates from 31 different patients while three new
DSTs (DST2286, DST2289, and DST2292) were obtained from
six different patients in three clusters and in each case, the two
patients infected with the same genotype were treated in two
different hospitals. Among the four major hospitals, the ratio of
new DSTs detected among total DSTs was nearly same (∼50%) in
Mubarak Al-Kabeer hospital (10 of 23, 43%), Ibn-Sina Hospital
(7 of 13, 54%) and Farwaniya Hospital (7 of 14, 50%) but was
lower from Maternity Hospital (4 of 17, 24%), however, the
difference was not statistically significant. Similarly, the ratio of
new DSTs detected among total DSTs in expatriate patients (5 of
12, 42%), and Kuwaiti patients (29 of 66, 44%) was also nearly
same (Supplementary Table 1). The C. albicans isolate (Kw1104)
resistant to fluconazole and voriconazole belonged to DST1056.
The newly identified alleles and DSTs have been submitted to the
publicly availableC. albicansMLST database (http://pubmlst.org/
calbicans/).
Overall, 55 C. albicans isolates from 55 patients belonged
to 55 unique DSTs (including 31 new DSTs) while 47 isolates
from 47 patients were clustered in 16 DSTs. The largest cluster
represented by DST656 contained nine isolates from nine
patients hospitalized in three hospitals followed by three other
clusters (represented by DST79, DST659, and DST1717) with
each cluster shared by four isolates and involving patients from
2 to 3 hospitals (Figure 1 and Table 3). Two other clusters
(represented by DST601 and DST840) contained three isolates
each, with DST601 yielding C. albicans isolates from Maternity
Hospital only. The remaining 10 clusters contained only two
isolates in each cluster and the two patients yielding C. albicans
isolates in only one cluster (DST1133) were hospitalized in the
same hospital (Figure 1 and Table 3). The analysis of MLST
data also showed that patients in nearly all clusters were
distributed across various hospitals in Kuwait (Figure 2). Repeat
bloodstream isolates as well as surveillance cultures obtained
from different anatomical sites yielded the same MLST genotype
as the first bloodstream isolate recovered from the same patient
(data not shown).
When the patient’s clinical and epidemiological data, date
of isolation of the C. albicans isolate and the hospital where
the patients were treated were considered, only four clusters
involving two isolates in each cluster were identified which
could potentially represent patient-to-patient or nosocomial
transmission of infection. In each case, both patients (including
4 neonates) were infected with relatively rare DSTs, developed
candidemia within a span of 46 days and were admitted to the
same intensive care unit/ward and/or were attended by the same
heath care personnel suggesting cross-transmission of infection
(Table 3). The remaining cluster isolates were epidemiologically
unrelated as they were recovered from patients hospitalized
in different hospitals and/or were recovered at considerably
different time points even from patients treated within the same
hospital.
Fingerprinting of Cluster C. albicans
Isolates by AFLP Analysis
A total of eight (Kw3196, Kw2765, Kw2603, Kw3306, Kw3442,
Kw3039, Kw3489, and Kw2256) C. albicans isolates from eight
patients in four DST (DST79, DST601, DST656, and DST1717)
clusters were subjected to further fingerprinting by amplified
fragment length polymorphism (AFLP). Reference C. albicans
(ATCC90028) and C. parapsilosis (CBS6318, CBS1954, and
ATCC22019) strains were also used for comparisons. Three
reference strains of C. parapsilosis were used to confirm the
robustness of AFLP data. Two C. parapsilosis strains (CBS6318
and CBS1954) are extremely closely related strains sharing 98.9%
identity while C. parapsilosis ATCC22019 is distantly related
to CBS6318 and CBS1954 and shares only 76% identity. The
results of AFLP confirmed these data as the AFLP patterns
for C. parapsilosis CBS6318 and CBS1954 were >98% identical.
The eight C. albicans isolates yielded a total of 115 AFLP
fragments of which 95 were polymorphic. An arbitrary cut-
off value of ≤95% similarity among AFLP patterns was used
for defining a distinct genotype. All eight isolates yielded eight
different AFLP fingerprinting patterns and eight distinct AFLP
genotypes (labeled as AFLP1 to AFLP8) (Figure 3). The cluster
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FIGURE 1 | An UPGMA-derived dendrogram based on allele numbers of seven housekeeping gene fragments from 102 bloodstream C. albicans
isolates from 102 patients. Similarity is presented in percentages using the scale bar in the upper left corner. The columns after the isolate numbers refer to the
MLST-based DSTs, name of hospital where candidemia patients were hospitalized, date of culture of the isolate and cluster number if two or more isolates belonged
to the same DST. NA, not applicable.
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TABLE 3 | Date and place of isolation of C. albicans isolates yielding identical multilocus sequence type (MLST)-based diploid sequence types (DSTs) in
16 clusters.
Patient Isolate Date of isolation Hospital Hospital MLST-based Cluster
no. no. (DD-MM-YY) warda DST no.e
6 Kw891 26-03-11 Al-Sabah ICU 656b I
15 Kw2019 14-06-11 Al-Sabah PICU 656b I
60 Kw554 10-02-12 Al-Sabah 1 656b I
16 Kw2079 17-06-11 Mubarak Al-Kabeer 11 656b I
31 Kw2784 06-09-11 Mubarak Al-Kabeer 9 656b I
95 Kw288 18-04-13 Mubarak Al-Kabeer 17 656b I
30 Kw2765 06-09-11 Ibn-Sina ICU 656b I
42 Kw3196 16-10-11 Ibn-Sina 7 656b I
54 Kw195 16-01-12 Ibn-Sina PICU 656b I
48 Kw3442 01-11-11 Maternity NICU-2 79c II
49 Kw3489 01-11-11 Maternity NICU-1 79c II
73 Kw278 28-06-12 Maternity NICU-1 79c II
86 Kw107 07-12-12 Mubarak Al-Kabeer ICU 79c II
18 Kw2256 04-07-11 Mubarak Al-Kabeer 24 1717b III
27 Kw2603 10-08-11 Mubarak Al-Kabeer 23 1717b III
83 Kw284 13-10-12 Maternity NICU-1 1717b III
87 Kw73 07-12-12 Ibn-Sina 7 1717b III
17 Kw2247 04-07-11 Farwaniya CCU 659b IV
64 Kw811 02-03-12 Ibn-Sina Medical 659b IV
91 Kw366 27-01-13 Ibn-Sina 7 659b IV
101 Kw2736 20-07-13 Ibn-Sina ICU 659b IV
9 Kw1311 09-04-11 Mubarak Al-Kabeer 12 840b V
11 Kw1443 18-04-11 Al-Amiri ICU 840b V
58 Kw541 09-02-12 Farwaniya NICU-8 840b V
7 Kw1158 27-03-11 Maternity SCU-2 601b VI
33 Kw3039 18-09-11 Maternity NICU-1 601b VI
39 Kw3306 13-10-11 Maternity SCU-1 601b VI
62 Kw606 13-02-12 Maternity SCU-1 277c VII
72 Kw77 08-06-12 Jahra SCU-1 277c VII
88 Kw216 16-12-12 Mubarak Al-Kabeer 12 365b VIII
100 Kw276 18-07-13 Farwaniya 8 365b VIII
8 Kw1275 05-04-11 Farwaniya NICU-8 620b IX
38 Kw3541 13-10-11 Mubarak Al-Kabeer 22 620b IX
70 Kw262 25-05-12 Ibn-Sina 7 927b X
76 Kw287 23-07-12 Maternity NICU-1 927b X
24 Kw2558 30-07-11 Maternity NICU-1 1097b XI
51 Kw3766 03-12-11 Jahra 6 1097b XI
10 Kw1342 11-04-11 Mubarak Al-Kabeer ICU 1133b XII
43 Kw3276 21-10-11 Al-Sabah 1 1133b XII
63 Kw575 13-02-12 Mubarak Al-Kabeer Medical 1363b XIII
75 Kw98 09-07-12 Mubarak Al-Kabeer ICU 1363b XIII
14 Kw1894 30-05-11 Mubarak Al-Kabeer 22 2286d XIV
19 Kw2283 04-07-11 Farwaniya NICU-8 2286d XIV
23 Kw2418 23-07-11 Farwaniya SCU-B 2289d XV
29 Kw2691 24-08-11 Mubarak Al-Kabeer 26 2289d XV
28 Kw2728 21-08-11 Maternity NICU-1 2292d XVI
44 Kw3376 27-10-11 Jahra 27 2292d XVI
a ICU, intensive care unit; PICU, pediatric intensive care unit; NICU, neonatal intensive care unit; SCU, special care unit; CCU, coronary care unit.
bRare genotypes.
cRelatively more common genotypes.
dNew genotypes found in this study.
eCluster isolates with identical DST and epidemiological linkage are shown in bold.
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FIGURE 2 | Minimum spanning tree of 102 C. albicans isolates derived
from MLST data. Each circle corresponds to a unique genotype, and lines
between circles represent relative distance between isolates. The sizes of the
circles correspond to the number of isolates of the same genotype (DST). The
numbers refer to the MLST-based DSTs. Connecting lines correspond to the
number of differences between genotypes, with a solid thick line connecting
genotypes that differ in one locus, a solid thin line connecting genotypes that
differ in two-three loci, a dashed line connecting genotypes that differ in four
loci, and a dotted line connecting genotypes that differ in more than four loci.
isolates exhibited 44 to 87% identity among each other based
on AFLP patterns. Interestingly, isolate Kw2603 belonging to
DST1717 exhibited closer relationship with the isolates (Kw3196
and Kw2765) in DST656 cluster than with isolate Kw2256
belonging to the same (DST1717) genotype. Similar results were
obtained for the two (Kw3306 and Kw3039) isolates in DST601
cluster (Figure 3). The AFLP data ruled-out patient-to-patient or
nosocomial transmission of infection among candidemia patients
in Kuwait.
DISCUSSION
The genetic diversity among clinical C. albicans isolates is
investigated by molecular typing techniques amenable to
high-throughput capability for epidemiological purposes.
These studies have occasionally identified small outbreaks
inside hospitals which escaped identification by routine
hospital infection control measures (Song et al., 2014; Tsai
et al., 2015). This study was carried out for two specific
objectives: to generate long-term genetic database of C.
albicans bloodstream isolates at seven major/tertiary care
hospitals and to identify endemic genotypes/cluster isolates
that could point toward patient-to-patient or nosocomial
transmission of infection among candidemia patients in
Kuwait.
Two PCR-based methods, viz. MLST and MLMT have been
mostly used in recent years to study global epidemiology, to
track outbreaks and to ascertain nosocomial transmission of C.
albicans infection (Bougnoux et al., 2003; Tavanti et al., 2003,
2005). Most of the molecular epidemiological investigations
focusing on the population structure of clinical C. albicans
isolates have typically relied on fingerprinting patterns by
either MLST or MLMT. Based on these analyses, some studies
have reported the occurrence of endemic genotypes in some
hospitals in few countries treating candidemia patients and
have suggested patient-to-patient or nosocomial transmission
of infection based on identification of cluster isolates with
identical C. albicans genotypes (Escribano et al., 2013; Marcos-
Zambrano et al., 2015; Tsai et al., 2015; Wu et al., 2015).
On the other hand, one recent study failed to observe any
epidemiological relationship among cluster isolates with identical
DSTs with respect to time of isolation or clinical units within the
hospital, thus ruling out nosocomial transmission of infection
(Huyke et al., 2015). These contrasting observations could be
attributed to the inherent disadvantages associated with the two
typing methods. Although, the loci are scattered on different
chromosomes, bothMLST andMLMT analyze very small regions
of C. albicans genome in contrast to other techniques such as
pulse field gel electrophoresis (PFGE), random amplification of
polymorphic DNA (RAPD) and AFLP which potentially examine
the entire genome (Ahmad et al., 2003; Borst et al., 2003;
Garcia-Hermoso et al., 2007; Odds et al., 2007; McManus and
Coleman, 2014). Thus, many closely related but genotypically
different isolates may yield identical genotype by MLST or
MLMT due to lower discriminatory power of these typing
techniques. Consistent with these observations, few studies which
analyzed the population structure of C. albicans isolates in
various settings by more than one molecular fingerprinting
technique also seem to support the endogenous origin of most
infections (Shin et al., 2011; Ge et al., 2012; Song et al.,
2014).
Our initial molecular fingerprinting performed on 102
clinical C. albicans bloodstream isolates obtained from 102
candidemia patients admitted in seven major hospitals in Kuwait
(representing >92% of all candidemia cases at these hospitals
within the 31-month study period) by MLST identified 55
isolates as unique strains (DSTs or genotypes) while 47 isolates
were grouped in 16 DSTs (clusters). Repeat bloodstream isolates
and surveillance cultures yielded the same MLST genotype
as the first bloodstream isolate from each patient. Similar
results have also been reported by investigators who have
analyzed multiple samples from candidemia patients (Cliff
et al., 2008; Afsarian et al., 2015; Moorhouse et al., 2016).
Interestingly 12 DSTs were found among 12 C. albicans isolates
from expatriate candidemia patients originating from four
Frontiers in Microbiology | www.frontiersin.org 8 February 2017 | Volume 8 | Article 247
Asadzadeh et al. Molecular Fingerprinting of C. albicans in Kuwait
FIGURE 3 | An UPGMA-derived dendrogram based on AFLP fingerprints for eight C. albicans isolates from eight patients found in four DST clusters.
The reference C. albicans strain (ATCC 90028) was also included in AFLP analysis and three reference strains of C. parapsilosis (CBS 6318, CBS 1954, ATCC 22019)
were used as outer groups. Similarity is presented in percentages using the scale bar in the upper left corner. The columns after the species represent isolate number,
date of isolation, DST, and arbitrarily defined AFLP genotype.
different countries while 64 DSTs (five DSTs were common
among the two groups) were found among 90 isolates from
Kuwaiti patients. The relatively large number of MLST-based
genotypes detected among Kuwaiti candidemia patients was
rather surprising since consanguineous marriages common
among Kuwaiti nationals are expected to favor selection of
relatively fewer C. albicans genotypes (Hoben et al., 2010).
DST656 was the most common genotype shared among nine
isolates. According to the MLST website (http://pubmlst.org/
calbicans/), DST656 is a rare genotype comprising isolates
originating from only six countries and mostly including
isolates from Kuwait and the U.K. Of DST79 and DST1717,
each comprising four cluster isolates, DST79 has a worldwide
distribution while DST1717 is a minor genotype mainly
including isolates from Kuwait and four isolates from three
other countries. DST601, DST659, and DST840, each comprising
three cluster isolates are also minor genotypes mainly including
isolates from Kuwait and a few other countries. These findings
suggested that the clustering of some C. albicans isolates in
rare MLST genotypes more common in some geographical
locations may be due to lower discriminatory power of MLST
rather than any specific genotypic (clonal) relationship. We
therefore, devised a strategy for determining whether cluster
isolates represent patient-to-patient or nosocomial transmission
of infection among candidemia patients in Kuwait and it is
outlined in Figure 4.
The patient’s clinical and epidemiological data were reviewed
and combined with the date of isolation of the cluster C.
albicans isolates and the MLST genotype. The C. albicans
isolates were considered as epidemiologically unrelated strains
if the cluster isolates were obtained from candidemia patients
in Kuwait from different hospitals or were cultured >60 days
apart even if they belonged to a rare MLST-based DST. One
study from South Korea has also shown that MLST-based
cluster isolates recovered from pairs of patients more than 2
months apart were genotypically distinct strains (Shin et al.,
2011). Other investigators have used different cut-off time
periods for defining cluster isolates with epidemiological linkage
causing bloodstream infections. The window period to define
FIGURE 4 | Flow diagram showing the steps adopted to confirm or rule
out intrahospital transmission of C. albicans infection among
candidemia patients in Kuwait. Cluster isolates with identical DST cultured
from two or more candidemia patients in the same hospital within 60 days
were considered possible candidates for intrahospital transmission of infection
and were further analyzed by AFLP fingerprinting. No intrahospital
transmission of infection was deduced based on eight unique AFLP patterns
exhibited by eight MLST-based cluster isolates.
epidemiological relationship with regard to time of isolation of
cluster isolates has ranged from ∼15 days (Huyke et al., 2015)
to 90 days (∼3 months) (Tsai et al., 2015). Some investigators
have used a 6-month period (Song et al., 2014) or even a
much broader window-period that ranged from few days to >1
year (Escribano et al., 2013; Marcos-Zambrano et al., 2015).
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Based on the criteria defined above for cluster isolates in
Kuwait, eight isolates in four clusters were presumed to be
epidemiologically linked and represented C. albicans isolates
with the possibility of intrahospital transmission of infection
among candidemia patients (Figure 4). Only two isolates from
the largest cluster fulfilled these criteria as the remaining isolates
in this cluster were either isolated in different hospitals and/or
the duration between their isolation was much longer. However,
among the three other clusters, two clusters involved four
neonates admitted to the intensive care units of Maternity
Hospital.
Additional fingerprinting of cluster isolates by whole genome-
based AFLP showed that all eight isolates were distinct
strains as cluster isolates exhibited ≤87% identity among
each other while clonal strains of Candida spp. exhibit
>95% identity in AFLP patterns (Chowdhary et al., 2014;
Asadzadeh et al., 2015; Schelenz et al., 2016). Furthermore,
>82% of AFLP fragments were polymorphic suggesting the
occurrence of frequent recombination events among Kuwaiti
strains that significantly contributed to the genetic diversity
of these isolates during AFLP analyses. Our data also showed
that despite the possibility of frequent recombination among
the strains, the MLST analyses were not able to detect
intra-strain variability, possibly reflecting the limitation of
using a very restricted set (only seven housekeeping gene
fragments) of gene loci in the currently used MLST scheme for
C. albicans.
The AFLP analyses ruled out patient-to-patient or nosocomial
transmission of infection in Kuwait. The fingerprinting of C.
albicans isolates from Jena in Germany by MLST identified only
two cluster isolates obtained from two neonates from an identical
ward and within a short period of 9 days. Epidemiological
investigations revealed that the patients were newborn twins
strongly suggesting transmission of C. albicans from the mother
rather than intrahospital transmission of infection (Huyke
et al., 2015). Only few studies have performed fingerprinting
of C. albicans isolates by more than one high-resolution typing
techniques. Twenty C. albicans isolates obtained from patients
with genital candidiasis in China and belonging to DST79
were classified into 11 microsatellite-based (CAI) genotypes
showing genotypic heterogeneity among MLST-based cluster.
Similarly, 26 cluster isolates belonging to a newly described
genotype (DST1867) comprised seven CAI genotypes showing
that cluster C. albicans isolates belonging to same MLST-based
DST are not always clonal (Ge et al., 2012). In two candidemia
studies originating from South Korea, initial fingerprinting
was performed by MLST followed by PFGE. Interestingly,
48 of 61 (79%) cluster isolates by MLST in one study were
reported as unrelated strains by PFGE even though only two
cluster isolates shared identical PFGE pattern (Shin et al., 2011).
Surprisingly, the remaining 11 isolates were considered as
“similar” (clonally related) strains even though they exhibited up
to 5% variations in PFGE banding patterns, a finding that should
have also placed them as genotypically distinct strains since they
belonged to the same DST and are expected, if not clonal, to be
closely-related but not identical (Shin et al., 2011). In another
study spanning 8 years and involving 43 neonates, only 9 of
28 (32%) cluster isolates by MLST were reported as unrelated
strains by PFGE. The C. albicans isolates from 14 patients yielded
same MLST/PFGE pattern while isolates from five patients
exhibited same MLST and similar (defined as ≥95% identical)
PFGE pattern (Song et al., 2014). Although, in one case, the
two MLST/PFGE cluster (DST182/PFGEtype10a) isolates were
cultured 3-years apart, three isolates in one MLST/PFGE
cluster (DST79/PFGEtype1), three isolates in a second
MLST/PFGE cluster (DST1097/PFGEtype14), three isolates
in a third MLST/PFGE cluster (DST2088/PFGEtype29) and
two isolates in one MLST/PFGE cluster (DST69/PFGEtype24)
were cultured within a short period of time (<50 days). Based
on these observations, the authors concluded that horizontal
transmission of C. albicans occurs more frequently than vertical
transmission among neonates hospitalized in NICUs (Song et al.,
2014). However, it is also probable that these C. albicans isolates
were closely related and PFGE could not resolve their genotypic
differences. Our results involving 21 neonatal candidemia
patients treated in intensive care units of Maternity Hospital in
Kuwait support the latter possibility as we did not identify any
episode of intrahospital transmission of C. albicans infection.
The study emphasizes the need of using more sensitive and
discriminatory molecular techniques to confirm or rule out
intrahospital transmission of Candida infection and to develop
preventive strategies in the event of presence of endemic
genotypes in a given clinical setting. Interestingly, analogous
observations have already been made for S. aureus, a nosocomial
opportunistic bacterial pathogen (Long et al., 2014; Price et al.,
2014; Roisin et al., 2016).
A limitation of our study is that the AFLP analyses were
not carried out on repeat C. albicans isolates from six patients
and the nine surveillance cultures that were investigated by
MLST.
AUTHOR CONTRIBUTIONS
Conceived and designed the experiments: MA, SA, NA, and ZK.
Performed the experiments: MA. Analyzed the data: MA, SA,
NA, and ZK. Contributed reagents/materials/analysis tools: ZK.
Wrote the paper: MA, SA, NA, and ZK.
ACKNOWLEDGMENTS
This study was supported by College of Graduate Studies, Kuwait
University and Research Sector grant YM 10/11 and Research
Core Facility grant SRUL02/13. We thank Ferry Hagen and
Jacques Meis for their help with AFLP analyses.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2017.00247/full#supplementary-material
Frontiers in Microbiology | www.frontiersin.org 10 February 2017 | Volume 8 | Article 247
Asadzadeh et al. Molecular Fingerprinting of C. albicans in Kuwait
REFERENCES
Afsarian, M. H., Badali, H., Boekhout, T., Shokohi, T., and Katiraee, F. (2015).
Multilocus sequence typing of Candida albicans isolates from a burn intensive
care unit in Iran. J. Med. Microbiol. 64, 248–253. doi: 10.1099/jmm.0.000015
Ahmad, S., Khan, Z., Asadzadeh, M., Theyyathel, A., and Chandy, R. (2012).
Performance comparison of phenotypic and molecular methods for detection
and differentiation of Candida albicans and Candida dubliniensis. BMC Infect.
Dis. 12:230. doi: 10.1186/1471-2334-12-230
Ahmad, S., Khan, Z., Mustafa, A. S., and Khan, Z. U. (2003). Epidemiology of
Candida colonization in an intensive care unit of a teaching hospital in Kuwait.
Med. Mycol. 41, 487–493. doi: 10.1080/1369378031000147458
Ahmad, S., Mustafa, A. S., Khan, Z., Al-Rifaiy, A. I., and Khan, Z. U. (2004). PCR-
enzyme immunoassay of rDNA in the diagnosis of candidemia and comparison
with amplicon detection by agarose gel electrophoresis. Int. J. Med. Microbiol.
294, 45–51. doi: 10.1016/j.ijmm.2004.01.002
Asadzadeh, M., Ahmad, S., Hagen, F., Meis, J. F., Al-Sweih, N., and Khan, Z.
U. (2015). Simple, low-cost detection of Candida parapsilosis complex isolates
and molecular fingerprinting of Candida orthopsilosis strains in Kuwait by ITS
region sequencing and amplified fragment length polymorphism analysis. PLoS
ONE 10:e0142880. doi: 10.1371/journal.pone.0142880
Asadzadeh, M., Al-Sweih, N. A., Ahmad, S., and Khan, Z. U. (2008). Antifungal
susceptibility of clinical Candida parapsilosis isolates in Kuwait. Mycoses 51,
318–323. doi: 10.1111/j.1439-0507.2008.01492.x
Asmundsdóttir, L. R., Erlendsdóttir, H., Haraldsson, G., Guo, H., Xu, J., and
Gottfredsson, M. (2008). Molecular epidemiology of candidemia: evidence of
clusters of smoldering nosocomial infections. Clin. Infect. Dis. 47, e17–e24.
doi: 10.1086/589298
Borst, A., Theelen, B., Reinders, E., Boekhout, T., Fluit, A. C., and Savelkoul, P.
H. (2003). Use of amplified fragment length polymorphism analysis to identify
medically important Candida spp., including C. dubliniensis. J. Clin. Microbiol.
41, 1357–1362. doi: 10.1128/JCM.41.4.1357-1362.2003
Bougnoux, M. E., Tavanti, A., Bouchier, C., Gow, N. A., Magnier, A., Davidson,
A. D., et al. (2003). Collaborative consensus for optimized multilocus
sequence typing of Candida albicans. J. Clin. Microbiol. 41, 5265–5266.
doi: 10.1128/JCM.41.11.5265-5266.2003
Chowdhary, A., Anil Kumar, V., Sharma, C., Prakash, A., Agarwal, K.,
Babu, R., et al. (2014). Multidrug-resistant endemic clonal strain of
Candida auris in India. Eur. J. Clin. Microbiol. Infect. Dis. 33, 919–926.
doi: 10.1007/s10096-013-2027-1
Cliff, P. R., Sandoe, J. A., Heritage, J., and Barton, R. C. (2008). Use
of multilocus sequence typing for the investigation of colonisation by
Candida albicans in intensive care unit patients. J. Hosp. Infect. 69, 24–32.
doi: 10.1016/j.jhin.2008.02.006
Clinical and Laboratory Standards Institute (2012). Reference Method for Broth
Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational
Supplement, M27-S4. Wayne, PA: Clinical and Laboratory Standards Institute.
Escribano, P., Rodríguez-Créixems, M., Sánchez-Carrillo, C., Muñoz, P., Bouza,
E., and Guinea, J. (2013). Endemic genotypes of Candida albicans causing
fungemia are frequent in the hospital. J. Clin. Microbiol. 51, 2118–2123.
doi: 10.1128/JCM.00516-13
Fitzpatrick, M. A., Ozer, E. A., and Hauser, A. R. (2016). Utility of whole-genome
sequencing in characterizing Acinetobacter epidemiology and analyzing
hospital outbreaks. J. Clin. Microbiol. 54, 593–612. doi: 10.1128/JCM.01818-15
Garcia-Hermoso, D., Cabaret, O., Lecellier, G., Desnos-Ollivier, M., Hoinard, D.,
Raoux, D., et al. (2007). Comparison of microsatellite length polymorphism
and multilocus sequence typing for DNA-Based typing of Candida albicans. J.
Clin. Microbiol. 45, 3958–3963. doi: 10.1128/JCM.01261-07
Ge, S. H., Xie, J., Xu, J., Li, J., Li, D. M., Zong, L. L., et al. (2012). Prevalence
of specific and phylogenetically closely related genotypes in the population of
Candida albicans associated with genital candidiasis in China. Fungal Genet.
Biol. 49, 86–93. doi: 10.1016/j.fgb.2011.10.006
Hoben, A. D., Buunk, A. P., Fincher, C. L., Thornhill, R., and Schaller, M. (2010).
On the adaptive origins and maladaptive consequences of human inbreeding:
parasite prevalence, immune functioning, and consanguineous marriage. Evol.
Psychol. 8, 658–676. doi: 10.1177/147470491000800408
Huyke, J., Martin, R., Walther, G., Weber, M., Kaerger, K., Bougnoux, M. E., et al.
(2015). Candida albicans bloodstream isolates in a German university hospital
are genetically heterogenous and susceptible to commonly used antifungals. Int.
J. Med. Microbiol. 305, 742–747. doi: 10.1016/j.ijmm.2015.08.027
Illnait-Zaragozí, M. T., Martínez-Machín, G. F., Fernández-Andreu, C.
M., Perurena-Lancha, M. R., Theelen, B., Boekhout, T., et al. (2012).
Environmental isolation and characterisation of Cryptococcus species
from living trees in Havana city, Cuba. Mycoses 55, e138–e144.
doi: 10.1111/j.1439-0507.2012.02168.x
Kett, D. H., Azoulay, E., Echeverria, P. M., and Vincent, J. L. (2011). Extended
Prevalence of Infection in ICU Study (EPIC II) Group of Investigators.
Candida bloodstream infections in intensive care units: analysis of the extended
prevalence of infection in intensive care unit study.Crit. CareMed. 39, 665–670.
doi: 10.1097/CCM.0b013e318206c1ca
Kumamoto, C. A. (2011). Inflammation and gastrointestinalCandida colonization.
Curr. Opin. Microbiol. 14, 386–391. doi: 10.1016/j.mib.2011.07.015
Kwong, J. C., Mercoulia, K., Tomita, T., Easton, M., Li, H. Y., Bulach, D.
M., et al. (2016). Prospective whole-genome sequencing enhances national
surveillance of Listeria monocytogenes. J. Clin. Microbiol. 54, 333–342.
doi: 10.1128/JCM.02344-15
Leroy, O., Gangneux, J. P., Montravers, P., Mira, J. P., Gouin, F., Sollet, J.
P., et al. (2009). Epidemiology, management, and risk factors for death
of invasive Candida infections in critical care: a multicenter, prospective,
observational study in France (2005–2006). Crit. Care Med. 37, 1612–1618.
doi: 10.1097/CCM.0b013e31819efac0
Liu, M., Huang, S., Guo, L., Li, H., Wang, F., Zhang, Q. I., et al. (2015). Clinical
features and risk factors for blood stream infections of Candida in neonates.
Exp. Ther. Med. 10, 1139–1144. doi: 10.3892/etm.2015.2626
Long, S. W., Beres, S. B., Olsen, R. J., and Musser, J. M. (2014). Absence of patient-
to-patient intrahospital transmission of Staphylococcus aureus as determined by
whole-genome sequencing.MBio 5, e01692–14. doi: 10.1128/mBio.01692-14
Maganti, H., Yamamura, D., and Xu, J. (2011). Prevalent nosocomial clusters
among causative agents for candidemia in Hamilton, Canada. Med. Mycol. 49,
530–538. doi: 10.3109/13693786.2010.547880
Marcos-Zambrano, L. J., Escribano, P., Sanguinetti, M., Gómez G de la
Pedrosa, E., De Carolis, E., Vella, A., et al. (2015). Clusters of patients with
candidaemia due to genotypes of Candida albicans and Candida parapsilosis:
differences in frequency between hospitals. Clin. Microbiol. Infect. 21, 677–683.
doi: 10.1016/j.cmi.2015.03.007
McBryde, E. S., Bradley, L. C., Whitby, M., and McElwain, D. L. (2004). An
investigation of contact transmission of methicillin-resistant Staphylococcus
aureus. J. Hosp. Infect. 58, 104–108. doi: 10.1016/j.jhin.2004.06.010
McManus, B. A., and Coleman, D. C. (2014). Molecular epidemiology,
phylogeny and evolution of Candida albicans. Infect. Genet. Evol. 21, 166–178.
doi: 10.1016/j.meegid.2013.11.008
Moorhouse, A. J., Rennison, C., Raza, M., Lilic, D., and Gow, N. A.
(2016). Clonal strain persistence of Candida albicans isolates from
chronic mucocutaneous candidiasis patients. PLoS ONE 11:e0145888.
doi: 10.1371/journal.pone.0145888
Moran, G. P., Coleman, D. C., and Sullivan, D. J. (2012). Candida albicans versus
Candida dubliniensis: why is C. albicans more pathogenic? Int. J. Microbiol.
2012:205921. doi: 10.1155/2012/205921
Neofytos, D., Fishman, J. A., Horn, D., Anaissie, E., Chang, C. H., Olyaei,
A., et al. (2010). Epidemiology and outcome of invasive fungal infections
in solid organ transplant recipients. Transpl. Infect. Dis. 12, 220–229.
doi: 10.1111/j.1399-3062.2010.00492.x
Nübel, U., Nachtnebel, M., Falkenhorst, G., Benzler, J., Hecht, J., Kube,
M., et al. (2013). MRSA transmission on a neonatal intensive care unit:
epidemiological and genome-based phylogenetic analyses. PLoS ONE 8:e54898.
doi: 10.1371/journal.pone.0054898
Odds, F. C., Bougnoux, M. E., Shaw, D. J., Bain, J. M., Davidson, A. D., Diogo,
D., et al. (2007). Molecular phylogenetics of Candida albicans. Eukaryot. Cell 6,
1041–1052. doi: 10.1128/EC.00041-07
Odds, F. C., and Jacobsen, M. D. (2008). Multilocus sequence typing of
pathogenic Candida species. Eukaryot. Cell 7, 1075–1084. doi: 10.1128/EC.
00062-08
Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., and Castanheira, M.
(2011). Geographic variations in species distribution and echinocandin
and azole antifungal resistance rates among Candida bloodstream
infection isolates: report from the SENTRY Antimicrobial Surveillance
Frontiers in Microbiology | www.frontiersin.org 11 February 2017 | Volume 8 | Article 247
Asadzadeh et al. Molecular Fingerprinting of C. albicans in Kuwait
Program (2008 to 2009). J. Clin. Microbiol. 49, 396–399. doi: 10.1128/JCM.
01398-10
Price, J. R., Golubchik, T., Cole, K., Wilson, D. J., Crook, D. W., Thwaites,
G. E., et al. (2014). Whole-genome sequencing shows that patient-to-patient
transmission rarely accounts for acquisition of Staphylococcus aureus in an
intensive care unit. Clin. Infect. Dis. 58, 609–618. doi: 10.1093/cid/cit807
Roisin, S., Gaudin, C., De Mendonça, R., Bellon, J., Van Vaerenbergh, K.,
De Bruyne, K., et al. (2016). Pan-genome multilocus sequence typing and
outbreak-specific reference-based single nucleotide polymorphism analysis to
resolve two concurrent Staphylococcus aureus outbreaks in neonatal services.
Clin. Microbiol. Infect. 22, 520–526. doi: 10.1016/j.cmi.2016.01.024
Sampaio, P., Gusmão, L., Correia, A., Alves, C., Rodrigues, A. G., Pina-Vaz, C.,
et al. (2005). New microsatellite multiplex PCR for Candida albicans strain
typing reveals microevolutionary changes. J. Clin. Microbiol. 43, 3869–3876.
doi: 10.1128/JCM.43.8.3869-3876.2005
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall,
A., et al. (2016). First hospital outbreak of the globally emerging Candida
auris in a European hospital. Antimicrob. Resist. Infect. Control. 5:35.
doi: 10.1186/s13756-016-0132-5
SenGupta, D. J., Cummings, L. A., Hoogestraat, D. R., Butler-Wu, S. M.,
Shendure, J., Cookson, B. T., et al. (2014). Whole-genome sequencing for
high-resolution investigation of methicillin-resistant Staphylococcus aureus
epidemiology and genome plasticity. J. Clin. Microbiol. 52, 2787–2796.
doi: 10.1128/JCM.00759-14
Shin, J. H., Bougnoux, M. E., d’Enfert, C., Kim, S. H., Moon, C. J., Joo, M. Y., et al.
(2011). Genetic diversity among KoreanCandida albicans bloodstream isolates:
assessment bymultilocus sequence typing and restriction endonuclease analysis
of genomic DNA by use of BssHII. J. Clin. Microbiol. 49, 2572–2577.
doi: 10.1128/JCM.02153-10
Song, E. S., Shin, J. H., Jang, H. C., Choi, M. J., Kim, S. H., Bougnoux, M. E., et al.
(2014). Multilocus sequence typing for the analysis of clonality among Candida
albicans strains from a neonatal intensive care unit. Med. Mycol. 52, 653–658.
doi: 10.1093/mmy/myu028
Stokes, C., Moran, G. P., Spiering, M. J., Cole, G. T., Coleman, D. C., and Sullivan,
D. (2007). Lower filamentation rates of Candida dubliniensis contribute to its
lower virulence in comparison with Candida albicans. Fungal Genet. Biol. 44,
920–931. doi: 10.1016/j.fgb.2006.11.014
Sun, H., Chen, Y., Zou, X., Li, H., Yin, X., Qin, H., et al. (2016). Occurrence of oral
Candida colonization and its risk factors among patients with malignancies in
China. Clin. Oral Investig. 20, 459–467. doi: 10.1007/s00784-015-1524-2
Tavanti, A., Davidson, A. D., Fordyce, M. J., Gow, N. A., Maiden, M. C., and
Odds, F. C. (2005). Population structure and properties of Candida albicans,
as determined by multilocus sequence typing. J. Clin. Microbiol. 43, 5601–5613.
doi: 10.1128/JCM.43.11.5601-5613.2005
Tavanti, A., Gow, N. A., Senesi, S., Maiden, M. C., and Odds, F. C. (2003).
Optimization and validation of multilocus sequence typing for Candida
albicans. J. Clin. Microbiol. 41, 3765–3776. doi: 10.1128/JCM.41.8.3765-
3776.2003
Tsai, M. H., Wang, S. H., Hsu, J. F., Lin, L. C., Chu, S. M., Huang, H. R., et al.
(2015). Clinical and molecular characteristics of bloodstream infections caused
by Candida albicans in children from 2003 to 2011. Clin. Microbiol. Infect. 21,
e1–e8. doi: 10.1016/j.cmi.2015.06.024
Ugolotti, E., Larghero, P., Vanni, I., Bandettini, R., Tripodi, G., Melioli, G.,
et al. (2016). Whole-genome sequencing as standard practice for the analysis
of clonality in outbreaks of meticillin-resistant Staphylococcus aureus in
a paediatric setting. J. Hosp. Infect. 93, 375–381. doi: 10.1016/j.jhin.2016.
04.003
Vincent, J. L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C. D.,
et al. (2009). International study of the prevalence and outcomes of
infection in intensive care units. JAMA 302, 2323–2329. doi: 10.1001/jama.
2009.1754
Wu, K., Luo, T., Li, L., Zhang, Q., Zhu, J., Gao, Q., et al. (2015). Multilocus
sequence typing of pathogenic Candida albicans isolates collected from a
teaching hospital in Shanghai, China: a molecular epidemiology study. PLoS
ONE 28:e0125245. doi: 10.1371/journal.pone.0125245
Zomorodian, K., Haghighi, N. N., Rajaee, N., Pakshir, K., Tarazooie, B., Vojdani,
M., et al. (2011). Assessment of Candida species colonization and denture-
related stomatitis in complete denture wearers. Med. Mycol. 49, 208–211.
doi: 10.3109/13693786.2010.507605
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Asadzadeh, Ahmad, Al-Sweih and Khan. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 12 February 2017 | Volume 8 | Article 247
